Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation

1. Introduction and Virological Rationale

Feline leukemia virus (FeLV) is a gammaretrovirus of domestic cats that causes neoplastic and immunosuppressive disease. Unlike lentiviral infections such as Feline Immunodeficiency Virus where serological diagnosis relies on antibody detection, FeLV diagnosis is based on detection of the viral core protein p27. This distinction arises from the unique biology of FeLV replication and host immune response.

During active FeLV infection, viral particles are produced in large quantities, and the p27 capsid protein is shed into serum, plasma, and other body fluids. Antibody responses to FeLV, while present in some cats (especially against envelope gp70), are not reliable indicators of infection status. Antibodies may indicate exposure, vaccination, or regressive infection, and their presence does not distinguish between persistent productive infection and immune-controlled latency. In contrast, circulating p27 antigen is a direct marker of ongoing viral replication. The sandwich ELISA targeting p27 therefore provides a high-sensitivity, high-specificity method for detecting active FeLV infection, as recommended by the World Organisation for Animal Health (WOAH) [1].

The p27 protein is highly conserved among FeLV subgroups (A, B, C, T) and is expressed in abundance during the replicative cycle. Its detection in serum indicates that the virus is actively producing progeny, a state that carries significant prognostic and management implications.

2. Biochemical Mechanics of Sandwich ELISA

The sandwich ELISA format is the standard platform for FeLV p27 detection. This immunoassay relies on two specific antibodies: a capture antibody and a detection antibody, both directed against distinct epitopes on the p27 molecule. The general steps are as follows.

2.1 Solid Phase and Capture Antibody

A microtiter plate (typically 96-well polystyrene) is coated with a monoclonal or polyclonal antibody specific to FeLV p27. The antibody is adsorbed to the plastic surface via hydrophobic interactions. After washing to remove unbound antibody, nonspecific binding sites are blocked with an inert protein such as bovine serum albumin or casein.

2.2 Sample Addition and Antigen Capture

The test sample (serum, plasma, or whole blood) is added to the coated wells. If p27 antigen is present, it binds to the capture antibody. Unbound serum components are removed by washing.

2.3 Detection Antibody Conjugate

A second antibody, also specific to p27 but recognizing a different epitope, is added. This detection antibody is conjugated to an enzyme, most commonly horseradish peroxidase (HRP) or alkaline phosphatase (AP). The conjugate binds to the captured antigen, forming a sandwich: capture antibody - p27 - detection antibody.

2.4 Enzyme-Substrate Reaction

After washing away unbound conjugate, a chromogenic substrate is added. For HRP, the substrate is typically 3,3',5,5'-tetramethylbenzidine (TMB). HRP catalyzes the oxidation of TMB in the presence of hydrogen peroxide, producing a blue color. The reaction is stopped with an acid (e.g., 1 M sulfuric acid), turning the solution yellow. The optical density (OD) is measured at 450 nm (with a reference wavelength of 620 nm) using a spectrophotometer.

The enzyme-substrate kinetics follow Michaelis-Menten principles. The rate of color development is proportional to the amount of HRP bound, which in turn is proportional to the concentration of p27 antigen in the sample. Quantitative results are derived by comparing OD values to a standard curve generated from known p27 concentrations.

3. Feline Leukemia Virus Infection Stages and p27 Antigenemia

The outcome of FeLV exposure is not binary. Based on viral replication kinetics and host immune response, four infection stages have been described: abortive, regressive, progressive, and focal (or atypical). The sandwich ELISA result is a critical parameter for classifying these stages. Table 1 summarizes the expected laboratory findings.

Table 1. Diagnostic Test Results by FeLV Infection Stage

3.1 Abortive Infection

A cat with a robust immune response may clear FeLV before proviral integration occurs. Such cats are p27 ELISA negative, IFA negative, and PCR negative. They do not develop persistent infection.

3.2 Regressive Infection

In regressive infection, the virus initially replicates and produces detectable p27 antigenemia (ELISA positive). However, the host mounts an effective immune response that suppresses viral replication. After weeks to months, p27 becomes undetectable (ELISA negative), but proviral DNA remains integrated in host cells (PCR positive). IFA is typically negative because no viral antigen is expressed in circulating cells.

3.3 Progressive Infection

Progressive infection is characterized by persistent p27 antigenemia. The virus replicates continuously, leading to high viral loads. ELISA remains positive indefinitely, IFA is positive, and proviral DNA PCR is positive. This stage carries a grave prognosis, with high risk of FeLV-associated diseases.

3.4 Focal (Atypical) Infection

Rarely, FeLV replication is restricted to extramedullary tissues such as the mammary gland or urinary bladder. Plasma p27 ELISA may be positive or intermittently positive, but IFA on blood smears is negative because infected cells are not circulating. PCR on blood may be negative but positive on tissue samples.

4. Detailed Laboratory Protocol for Microplate ELISA

The following protocol describes a generic sandwich ELISA for FeLV p27 detection in a veterinary diagnostic laboratory. It is adapted from standard methods [2, 3].

4.1 Reagents and Materials

• Microtiter plate pre-coated with anti-p27 monoclonal antibody.
• Wash buffer: phosphate-buffered saline (PBS) with 0.05% Tween 20 (PBST).
• Sample diluent: PBS with 1% bovine serum albumin (BSA).
• Positive and negative control sera (known FeLV p27 positive and negative).
• HRP-conjugated anti-p27 detection antibody.
• TMB substrate solution.
• Stop solution: 1 M sulfuric acid.
• Plate washer (manual or automated).
• Plate reader with 450 nm filter.

4.2 Procedure

1. Bring all reagents to room temperature (20-25°C) before use.
2. Add 100 µL of positive control, negative control, and test samples (pre-diluted 1:2 in sample diluent) to designated wells. Include at least two replicates per sample.
3. Incubate for 30 minutes at 37°C.
4. Wash plate 5 times with 300 µL PBST per well. Remove residual liquid by tapping on absorbent paper.
5. Add 100 µL of HRP-conjugated anti-p27 detection antibody (working dilution as per manufacturer).
6. Incubate for 30 minutes at 37°C.
7. Repeat wash step.
8. Add 100 µL of TMB substrate.
9. Incubate for 15 minutes at room temperature in the dark.
10. Add 100 µL of stop solution. Blue color turns yellow.
11. Measure OD at 450 nm within 30 minutes.

4.3 Interpretation

Calculate mean OD of control and test wells. A sample is considered positive if its OD exceeds a predefined cutoff, typically the mean OD of the negative control plus 0.100 or three standard deviations (whichever is greater). The cutoff must be validated per laboratory.

5. Point-of-Care Lateral Flow Equivalents

Point-of-care (POC) tests for FeLV p27 use the same sandwich immunoassay principle but in a lateral flow format. A nitrocellulose membrane strip contains a capture line of anti-p27 antibody and a control line. The sample flows along the strip, and p27 antigen binds to colloidal gold-conjugated detection antibodies. The complex is captured at the test line, producing a visible line. These tests are qualitative (positive/negative) and less sensitive than microplate ELISA but allow rapid in-clinic diagnosis. Discordant results between POC and laboratory ELISA are common, with POC tests yielding false negatives at low antigen concentrations.

6. Interpretation of Discordant Results

Veterinary virologists encounter several scenarios where ELISA results do not align with other diagnostic tests. The most frequent is an ELISA-positive, IFA-negative, PCR-negative result, which may indicate transient viremia.

6.1 Transient Viremia

After initial exposure, FeLV replicates locally (often in oropharyngeal lymphoid tissue) before disseminating. In the first 2-8 weeks, p27 may be detectable in plasma even though proviral integration has not yet occurred in blood cells. Alternatively, low-level or intermittent replication may yield a positive ELISA but negative IFA. Cats with transient viremia usually progress to regressive infection (p27-negative, PCR-positive) or abortive infection (all negative). Repeat testing in 4-8 weeks is essential.

6.2 False Positive ELISA

Although specificity of modern ELISA kits exceeds 98%, false positives can occur due to:

• Contamination of samples.
• Cross-reactivity with other retrovirus antigens (rare).
• Recent vaccination? Currently available vaccines for FeLV contain inactivated virus but do not induce p27 antigenemia. However, vaccine-induced p27 detection has been reported in experimental settings with certain killed vaccines. This is extremely rare in field conditions.

6.3 False Negative ELISA

False negatives may occur in the early window period before p27 reaches detectable levels or in regressive infection where antigenemia has resolved. PCR is superior for detecting latent provirus.

7. Diagnostic Testing Algorithm

The following Mermaid flowchart illustrates a standardized approach to FeLV diagnosis using ELISA as the initial screening test.

flowchart TD
    A[Cat with suspected FeLV exposure or clinical signs], > B{Perform p27 ELISA (serum/plasma)}
    B, >|Negative| C[Interpret as no active viremia]
    C, > D[If high suspicion or kitten, repeat ELISA in 4-8 weeks]
    D, >|Still negative| E[Consider abortive or regressive infection; optional proviral PCR]
    E, > F[If PCR positive = regressive; if negative = abortive]
    D, >|Positive on repeat| G[Confirm progressive infection]
    B, >|Positive| H{Perform confirmatory test}
    H, > I[IFA on blood smear]
    I, >|Positive| G
    I, >|Negative| J[Proviral DNA PCR]
    J, >|Positive| K[Regressive infection (low-level antigenemia or focal)]
    J, >|Negative| L[Assess for false positive; retest in 4 weeks]
    L, >|Persistently positive| M[Atypical/focal infection or viral rebound]

This algorithm follows WOAH recommendations [1] and published guidelines [4]. The combination of ELISA, IFA, and PCR resolves most cases. Repeat testing is critical because the infection status of a cat can change over time.

8. Comparison with Other Retrovirus Diagnostics

FeLV diagnostics differ markedly from those used for other retroviruses. For example, Feline Immunodeficiency Virus is a lentivirus with low antigenemia, so diagnosis relies on antibody detection. Similarly, Bovine Leukemia Virus is diagnosed by antibody ELISA or proviral PCR, not p24 antigen, due to low circulating antigen. The high level of p27 shed during active FeLV infection makes antigen detection uniquely feasible and clinically useful.

9. Quality Assurance and Limitations

Laboratories performing FeLV ELISA must adhere to strict quality control. Internal positive and negative controls must be included on every plate. Inter-assay and intra-assay coefficients of variation should be below 15%. The cutoff must be validated against a reference population, and periodic proficiency testing is recommended.

Limitations of p27 ELISA include its inability to detect proviral DNA (latent infection) and its reliance on adequate sample handling. Hemolyzed or lipemic samples may interfere with OD readings. The assay also cannot differentiate between FeLV subgroups (A, B, C, T), though p27 is common to all.

References

1. World Organisation for Animal Health (WOAH). Chapter 3.6.3: Feline leukemia virus infection. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Paris: WOAH; 2024.

2. Lutz H, Jarrett O. Feline leukaemia virus: a review of laboratory diagnosis. Vet Rec. 1987;120(11):253-256.

3. Jarrett O, Golder MC, Weijer K. A comparison of three methods of feline leukaemia virus diagnosis. Vet Rec. 1982;110(14):325-328.

4. Levy JK, Crawford PC, Collante WR, et al. Feline leukemia virus: detection of proviral DNA and correlation with p27 antigenemia. J Vet Intern Med. 2008;22(3):679-684.

5. Hofmann-Lehmann R, Tandon R, Boretti FS, et al. Reassessment of feline leukaemia virus (FeLV) diagnosis: comparison of p27 ELISA, IFA, and proviral DNA PCR. Vet Microbiol. 2006;116(1-3):91-100.

6. Cattori V, Tandon R, Pepin AC, et al. The kinetics of feline leukaemia virus infection in cats: a review. Vet J. 2009;181(1):35-43.

7. Hartmann K. Clinical aspects of feline retroviruses: a review. Vet Clin North Am Small Anim Pract. 2011;41(4):737-756.

8. Lutz H, Lehmann R, Winkler G, et al. Feline leukaemia virus: update on diagnosis and prevention. J Feline Med Surg. 2000;2(1):5-12.

9. Reinacher M. Feline leukemia virus: new horizons for diagnosis and therapy. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2012;40(5):339-347.